Details for Patent: 8,962,000
✉ Email this page to a colleague
Which drugs does patent 8,962,000 protect, and when does it expire?
Patent 8,962,000 protects OLUX E and VERDESO and is included in two NDAs.
This patent has twenty-two patent family members in sixteen countries.
Summary for Patent: 8,962,000
| Title: | Microemulsion and sub-micron emulsion process and compositions |
| Abstract: | An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, is provided. The composition includes an oil phase dispersed throughout a water phase, the oil phase including at least one member selected from the group consisting of an animal oil, a mineral oil, a vegetable oil, a silane member, a siloxane, an ester, a fatty acid, a fat, a halogen compound, and an alkoxylated alcohol; and at least one lipophilic surfactant, the water phase including at least one hydrophilic surfactant, water and optionally a non-surfactant amphiphilic compound, the weight ratio of the at least one hydrophilic surfactant to the at least one lipophilic surfactant being approximately 9.0:1.0 to 2.0:3.0. |
| Inventor(s): | Larm; Maria Graziella (Rosanna, AU), Harding; Ronald (North Warrandyte, AU), Johnston; Michael (Yarraville, AU), Abram; Albert Zorko (Wantirna, AU), Viyayakumar; Prema (Fremont, CA), Sun; Phoebe (Mountain View, CA) |
| Assignee: | Stiefel West Coast LLC (Wilmington, DE) |
| Application Number: | 13/873,777 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,962,000 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; Use; |
Drugs Protected by US Patent 8,962,000
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | AB2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES | ⤷ Try a Trial | ||
| Almirall | VERDESO | desonide | AEROSOL, FOAM;TOPICAL | 021978-001 | Sep 19, 2006 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF ATOPIC DERMATITIS | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,962,000
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 051197 | ⤷ Try a Trial | |||
| Australia | 2005279704 | ⤷ Try a Trial | |||
| Brazil | PI0514806 | ⤷ Try a Trial | |||
| Canada | 2578594 | ⤷ Try a Trial | |||
| Canada | 2756674 | ⤷ Try a Trial | |||
| China | 101048136 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
